Literature DB >> 35637317

Phenotypic drug discovery: recent successes, lessons learned and new directions.

Fabien Vincent1, Arsenio Nueda2, Jonathan Lee3, Monica Schenone4, Marco Prunotto5,6, Mark Mercola7.   

Abstract

Many drugs, or their antecedents, were discovered through observation of their effects on normal or disease physiology. For the past generation, this phenotypic drug discovery approach has been largely supplanted by the powerful but reductionist approach of modulating specific molecular targets of interest. Nevertheless, modern phenotypic drug discovery, which combines the original concept with modern tools and strategies, has re-emerged over the past decade to systematically pursue drug discovery based on therapeutic effects in realistic disease models. Here, we discuss recent successes with this approach, as well as consider ongoing challenges and approaches to address them. We also explore how innovation in this area may fuel the next generation of successful projects.
© 2022. Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35637317     DOI: 10.1038/s41573-022-00472-w

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   112.288


  207 in total

Review 1.  Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches.

Authors:  Jonathan A Lee; Ellen L Berg
Journal:  J Biomol Screen       Date:  2013-09-30

Review 2.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

Review 3.  How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice.

Authors:  Dorothea Haasen; Ulrich Schopfer; Christophe Antczak; Chantale Guy; Florian Fuchs; Paul Selzer
Journal:  Assay Drug Dev Technol       Date:  2017-08-11       Impact factor: 1.738

Review 4.  Opportunities and challenges in phenotypic drug discovery: an industry perspective.

Authors:  John G Moffat; Fabien Vincent; Jonathan A Lee; Jörg Eder; Marco Prunotto
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

Review 5.  The discovery of first-in-class drugs: origins and evolution.

Authors:  Jörg Eder; Richard Sedrani; Christian Wiesmann
Journal:  Nat Rev Drug Discov       Date:  2014-07-18       Impact factor: 84.694

6.  What Are the Odds of Finding a COVID-19 Drug from a Lab Repurposing Screen?

Authors:  Aled Edwards
Journal:  J Chem Inf Model       Date:  2020-09-11       Impact factor: 4.956

Review 7.  Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies.

Authors:  Fabien Vincent; Paula M Loria; Andrea D Weston; Claire M Steppan; Regis Doyonnas; Yue-Ming Wang; Kristin L Rockwell; Marie-Claire Peakman
Journal:  Cell Chem Biol       Date:  2020-09-03       Impact factor: 8.116

8.  Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners' Perspective.

Authors:  Kenneth M Comess; Shaun M McLoughlin; Jon A Oyer; Paul L Richardson; Henning Stöckmann; Anil Vasudevan; Scott E Warder
Journal:  J Med Chem       Date:  2018-06-06       Impact factor: 7.446

Review 9.  Hepatitis C - New drugs and treatment prospects.

Authors:  Marianna Zając; Izabela Muszalska; Agnieszka Sobczak; Adrianna Dadej; Szymon Tomczak; Anna Jelińska
Journal:  Eur J Med Chem       Date:  2019-01-14       Impact factor: 6.514

10.  Identification of hepatitis C virus NS5A inhibitors.

Authors:  Julie A Lemm; Donald O'Boyle; Mengping Liu; Peter T Nower; Richard Colonno; Milind S Deshpande; Lawrence B Snyder; Scott W Martin; Denis R St Laurent; Michael H Serrano-Wu; Jeffrey L Romine; Nicholas A Meanwell; Min Gao
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

View more
  2 in total

Review 1.  Repurposing drugs to treat cardiovascular disease in the era of precision medicine.

Authors:  Mena Abdelsayed; Eric J Kort; Stefan Jovinge; Mark Mercola
Journal:  Nat Rev Cardiol       Date:  2022-05-23       Impact factor: 49.421

2.  A tubulin binding molecule drives differentiation of acute myeloid leukemia cells.

Authors:  Thomas R Jackson; Aini Vuorinen; Laia Josa-Culleré; Katrina S Madden; Daniel Conole; Thomas J Cogswell; Isabel V L Wilkinson; Laura M Kettyle; Douzi Zhang; Alison O'Mahony; Deanne Gracias; Lorna McCall; Robert Westwood; Georg C Terstappen; Stephen G Davies; Edward W Tate; Graham M Wynne; Paresh Vyas; Angela J Russell; Thomas A Milne
Journal:  iScience       Date:  2022-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.